跳至主要内容
临床试验/IRCT20140818018842N25
IRCT20140818018842N25招募中3 期

Comparison of Myeloablative versus Reduced-Intensity conditioning regimen before Hematopoietic Cell Transplantation in Measurable Residual Disease negative, 50 years or older patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes and Acute Lymphoblastic Leukemia: A phase III Randomized Controlled Trial.

Tehran University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 65 years(—)
性别
All

入选标准

  • Patients from 50 to 65 years old
  • Patients with diagnosis of Myelodysplastic Syndromes , Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia who are Measurable Residual Disease negative pre-transplant within 30 days of enrollment.
  • Patient and donor are allowed to be a full match (8/8), or at least Human Leukocyte Antigens (HLA)-A, -B, -C and DRB1 matched.
  • Cardiac function: Ejection Fraction = 40%
  • Hepatic function: total bilirubin and Aspartate transaminase (AST) and alanine aminotransferase (ALT) = 2,5 x the upper limit of normal
  • Pulmonary function: Forced expiratory volume (FEV1) = 50%
  • Renal function: creatinine clearance > 40 mL/min based on the Cockroft-Gault formula
  • Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) score <4
  • Signed informed consent.

排除标准

  • Prior allogeneic stem cell transplantation
  • Symptomatic coronary artery disease
  • Karnofsky Performance Score < 70
  • Central nervous system involvement
  • Patients with uncontrolled bacterial, viral or fungal infection
  • Females who are pregnant or breastfeeding.
  • Patients seropositive for human immunodeficiency virus.

研究者

相似试验